EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)Open Access · CC BY 4.0

Stress and Coping During an HIV Cure-Related Trial with an Analytical Treatment Interruption: A Qualitative Assessment of the Experiences of Young Women in Durban, South Africa

Ali Ahmed iD, Miranda Hill, Krista L Dong iD, Mzwakhe Wiseman Ngcobo, Ayanda Zulu, Ntombifuthi Langa, Luyanda Maphalala, Vanessa Pillay, Maud Mthembu, Whitney Tran, Rachel Lau, Jamila K Stockman und 2 weitere

Journal of the International Association of Providers of AIDS Care (JIAPAC) · 2026-01 · 25

DOI: 10.1177/23259582261423985 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift Journal of the International Association of Providers of AIDS Care (JIAPAC), online erschienen am 13.02.2026. Verfasst von Ali Ahmed und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases and Global Public Health, School of Medicine, University of California, San Diego (UCSD), La Jolla, CA, USA. Hauptthemen laut MEDLINE: HIV Infections, Adaptation, Psychological, Stress, Psychological, Anti-HIV Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gates Foundation, NIMH NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Young women in sub-Saharan Africa bear a disproportionate HIV burden yet rarely participate in cure-related studies. Analytical treatment interruptions (ATI), used to assess sustained control off therapy, raise clinical, ethical, and psychosocial concerns.

Methods

We conducted a longitudinal qualitative study within a Phase 2A ATI trial (NCT05281510) at the FRESH site in Durban, South Africa. Nineteen women living with HIV (median age 26) completed in-depth interviews at 4 timepoints. We applied framework analysis informed by the Lazarus-Folkman stress and coping model.

Results

Participants enrolled to contribute to science, reduce pill burden, and due to trust in the clinical team. They anticipated viral rebound, resistance, stigma, and partner transmission. Over time, many reported improved emotional well-being, using meaning-based strategies (pride in contribution) and problem-focused strategies (self-monitoring, condom negotiation). Burdens included stigma, selective disclosure, partner resistance, frequent visits, and blood draws. Benefits included increased HIV literacy, self-management, and comfort with procedures.

Conclusion

ATI-inclusive clinical trials can be acceptable when designs include clear and ongoing education, strong confidentiality protections, mental health and peer support, partner-inclusive risk reductions, and flexible scheduling with practical supports to minimize participation burden and potential psychosocial harms. Clinical trial registration NCT05281510

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsAdaptation, PsychologicalStress, PsychologicalAnti-HIV AgentsHumansFemaleSouth AfricaTreatment InterruptionAdultCoping SkillsQualitative ResearchLongitudinal StudiesYoung Adult

Stichwörter der Autor:innen

HIV cure researchHIV preventionPrEPmental healthresource-limited settingswomen living with HIV

Substanzen

Anti-HIV Agents

Autor:innen und Institutionen

  • Division of Infectious Diseases and Global Public Health, School of Medicine, University of California, San Diego (UCSD), La Jolla, CA, USA.
  • Department of Obstetrics, Gynecology, and Reproductive Sciences, School of Medicine, University of California, San Francisco (UCSF), San Francisco, CA, USA.
  • Ragon Institute of Mass General Brigham, MIT, and Harvard, Cambridge, MA, USA.
  • Infectious Diseases Division, Massachusetts General Hospital, Boston, MA, USA.
  • Harvard Medical School, Cambridge, MA, USA.
  • Integration of TB in Education and Care for HIV/AIDS (ITEACH), Pietermaritzburg, South Africa.

ORCID-Profile: Ali Ahmed, Krista L Dong, Karine Dubé

Förderung

  • Gates Foundation
  • NIMH NIH HHS
  • NIAID NIH HHS
  • Wellcome Trust
  • National Institute of Mental Health
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Ahmed, A., Hill, M., Dong, K. L., Ngcobo, M. W., Zulu, A., Langa, N., Maphalala, L., Pillay, V., Mthembu, M., Tran, W., Lau, R., Stockman, J. K., Ndung'u, T., & Dubé, K. (2026). Stress and Coping During an HIV Cure-Related Trial with an Analytical Treatment Interruption: A Qualitative Assessment of the Experiences of Young Women in Durban, South Africa. Journal of the International Association of Providers of AIDS Care (JIAPAC), 25. https://doi.org/10.1177/23259582261423985

Vancouver

Ahmed A, Hill M, Dong KL, Ngcobo MW, Zulu A, Langa N, et al. Stress and Coping During an HIV Cure-Related Trial with an Analytical Treatment Interruption: A Qualitative Assessment of the Experiences of Young Women in Durban, South Africa. Journal of the International Association of Providers of AIDS Care (JIAPAC). 2026;25. doi:10.1177/23259582261423985

BibTeX
@article{Ahmed2026,
  author = {Ahmed, Ali and Hill, Miranda and Dong, Krista L and Ngcobo, Mzwakhe Wiseman and Zulu, Ayanda and Langa, Ntombifuthi and Maphalala, Luyanda and Pillay, Vanessa and Mthembu, Maud and Tran, Whitney and Lau, Rachel and Stockman, Jamila K and Ndung'u, Thumbi and Dubé, Karine},
  title = {Stress and Coping During an HIV Cure-Related Trial with an Analytical Treatment Interruption: A Qualitative Assessment of the Experiences of Young Women in Durban, South Africa},
  journal = {Journal of the International Association of Providers of AIDS Care (JIAPAC)},
  year = {2026},
  volume = {25},
  doi = {10.1177/23259582261423985}
}
Kostenlos starten →